hepatitis%20-%20viral
HEPATITIS - VIRAL
The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis.
Hepatitis A generally causes minor illness in childhood with >80% of infections being asymptomatic but more likely to produce clinical symptoms in adults. 
Hepatitis B, C, and D may also be asymptomatic.
Hepatitis A is predominantly transmitted through oral-fecal route.
Hepatitis B is transmitted through perinatal, percutaneous, or sexual routes or close person-to-person contact via open cuts and sores.
Hepatitis C infections are transmitted through perinatal, percutaneous, or sexual routes, blood transfusions, or organ transplants.
Hepatitis D's route of transmission is sexual or percutaneous, especially IV drug use.
Hepatitis E is transmitted primarily through contaminated drinking water and oral-fecal transmission.

Introduction

  • A self-limiting disease that is usually caused by viruses. As it progresses, it causes fibrosis (scarring), cirrhosis and cancer of the liver

Signs and Symptoms

  • The majority of acute viral hepatitis infections are asymptomatic or they can cause an anicteric illness that may not be diagnosed as hepatitis
  • Hepatitis A generally causes minor illness in childhood with >80% of infections being asymptomatic
    • Adults are more likely to produce clinical symptoms
  • Hepatitis B, C and D may also be asymptomatic
  • Symptomatic hepatitis B will depend on the mode and time of transmission
    • Vertical transmission from mother to child is almost always asymptomatic
    • Other routes of transmission are more likely to produce symptomatic disease (30% of cases transmitted by IV drug use are icteric)
Preicteric Phase
  • Nonspecific systemic symptoms (eg myalgia, nausea, vomiting, fatigue, malaise with discomfort in the right upper quadrant of the abdomen)
  • Altered sense of smell or taste, coryza, photophobia, headache, cough, diarrhea, dark urine and serum sickness-like syndrome
  • Hepatomegaly, splenomegaly and lymphadenopathy may be seen on physical exam
Icteric Phase
  • Jaundice, usually noted after onset of fever or upon lysis of fever
Fulminant Hepatitis
  • Development of symptoms of hepatic encephalopathy (eg confusion, drowsiness within 8 weeks of symptoms or within 2 weeks of onset of jaundice)
  • Hypoglycemia, prolonged prothrombin time (PT)

Pathogenesis

Routes of Transmission of Hepatitis

Hepatitis A: Oral-fecal

Hepatitis B: Perinatal, percutaneous, sexual, close person-to-person contact ie by open cuts and sores

Hepatitis C: Blood transfusions, organ transplants, percutaneous (especially IV drug use), sexual, perinatal

Hepatitis D: Sexual, percutaneous especially IV drug use

  • Found only in patients with hepatitis B since it requires the hepatitis B outer coat

Hepatitis E: Oral-fecal, blood transfusion in endemic areas

Incubation Period

Hepatitis A: 15-50 days

Hepatitis B: 40-180 days

Hepatitis C: 20-120 days

Hepatitis D: 30-180 days

Hepatitis E: 21-60 days

Other Characteristics of Hepatitis Viruses

  • Hepatitis B virus contains a DNA nucleic acid while A, C, and E viruses have an RNA nucleic acid
    • Hepatitis D has an incomplete RNA and needs the B virus to replicate
  • Hepatitis A and E viruses cause epidemics
  • Hepatitis B, C, and D viruses may predispose to chronic disease and hepatic malignancy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Saras Ramiya, 20 Feb 2018
US researchers show split liver transplantation and living donor liver transplantation (LDLT) may be superior to whole liver transplantation in improving outcomes in paediatric patients.
Pank Jit Sin, 27 Apr 2018
A multispecialty team of healthcare professionals in University of Malaya (UM) has successfully carried out their first living donor liver transplantation last year and since then performed three living donor liver transplants over the past year. 
Christina Lau, 22 Feb 2018

Cabozantinib, an oral inhibitor of multiple tyrosine kinases, significantly improves overall survival (OS) and progression-free survival (PFS) in patients with advanced hepatocellular carcinoma (HCC) whose disease progressed following sorafenib or other systemic therapies.

Pank Jit Sin, 28 Jun 2017
Liver Update is a series of international scientific meetings organized by the Malaysian Liver Foundation. It is meant to keep our healthcare professionals (HCPs) updated on current developments and new advances in the management of liver diseases. Usually held around mid to late July, the conference is a must-go for hepatologists, GPs and allied health professionals alike.